Hib vaccination in infants born prematurely

Archives of Disease in Childhood

Volumn 88, Issue 3, 2003, Pages 206-210

  Heath, P T ^a   Booy, R ^b   McVernon, J ^c   Bowen Morris, J ^c   Griffiths, H ^c   Slack, M P E ^c   Moloney, A C ^d   Ramsay, M E ^e   Moxon, E R ^c  

^a ST GEORGE S HOSPITAL   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^d WATERFORD REGIONAL HOSPITAL   (Ireland)

^e PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; HAEMOPHILUS INFLUENZAE VACCINE; PHOSPHATE;

ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; GEOMETRY; HAEMOPHILUS INFLUENZAE TYPE B; HEALTH SURVEY; HUMAN; IMMUNIZATION; IMMUNOGENICITY; INFANT; INFANT DISEASE; INFECTION PREVENTION; INFECTION RISK; INFLUENZA; INFLUENZA VACCINATION; IRELAND; NONHUMAN; OUTCOMES RESEARCH; PEDIATRICIAN; PREMATURITY; PRESCHOOL CHILD; PRIORITY JOURNAL; UNITED KINGDOM;

ANTIBODIES, BACTERIAL; COHORT STUDIES; FEMALE; GESTATIONAL AGE; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE TYPE B; HAEMOPHILUS VACCINES; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; MALE; POLYSACCHARIDES; RISK FACTORS; VACCINES, CONJUGATE;

EID: 0037373611     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.88.3.206     Document Type: Article

References (32)

1. Bernbaum JC, Daft A, Anolik R, et al. Response of preterm infants to diphtheria-tetanus-pertussis immunizations. J Pediatr 1985;107:184-8.
2. D'Angio CT, Maniscalco WM, Pichichero ME. Immunologic response of extremely premature infants to tetanus, Haemophilus influenzae, and polio immunizations. Pediatrics 1995;96(1 pt 1):18-22.
3. Ramsay ME, Miller E, Ashworth LAE, et al. Adverse events and antibody response to accelerated immunisation in term and preterm infants. Arch Dis Child 1995;48:230-2.
4. O'Shea TM, Dillard RG, Gillis DC, et al. Low rates of response to enhanced inactivated polio vaccine in preterm infants with chronic illness. Clin Res Reg Affairs 1993;10:49-57.
5. Conway S, James J, Balfour A, et al. Immunisation of the preterm baby. J Infect 1993;27:143-50.
6. Smolen P, Bland R, Heiligenstein E, et al. Antibody response to oral polio vaccine in premature infants. J Pediatr 1983;103:917-19.
7. Adenyi-Jones SC, Faden H, Ferdon MB, et al. Systemic and local immune responses to enhanced-potency inactivated poliovirus vaccine in premature and term infants. J Pediatr 1992;120:686-9.
8. Linder N, Yaron M, Handsher R, et al. Early immunization with inactivated poliovirus vaccine in premature infants. J Pediatr 1995;127(1):128-30.
9. Lau YL, Tam AY, Ng KW, et al. Response of preterm infants to hepatitis B vaccine. J Pediatr 1992;121:962-5.
10. Belson A, Reif S, Peled Y, et al. Immune response to hepatitis B virus vaccine in 1-year-old preterm and term infants. J Pediatr Gastroenterol Nutr 1996;23:252-5.
11. Chawareewong S, Jirapongsa A, Lokaphadhana K. Immune response to hepatitis B vaccine in premature neonates. Southeast Asian J Trop Med Public Health 1991;22:39-40.
12. del Canho R, Grosheide PM, Gerards LJ, et al. Hepatitis B vaccination and preterm infants. Pediatr Infect Dis J 1993;12:407-8.
13. Blondheim O, Bader D, Abend M, et al. Immunogenicity of hepatitis B vaccine in preterm infants. Arch Dis Child Fetal Neonatal Ed 1998;79:F206-8.
14. Munoz A, Salvador A, Brodsky NL, et al. Antibody response of low birth weight infants to Haemophilus influenzae type b polyribosylribitol phosphate-outer membrane protein conjugate vaccine. Pediatrics 1995;96(2 pt 1):216-19.
15. Washburn LK, O'Shea TM, Gillis DC, et al. Response to Haemophilus influenzae type b conjugate vaccine in chronically ill premature infants. J Pediatr 1993;123:791-4.
16. Kristensen K, Gyhrs A, Lausen B, et al. Antibody response to Haemophilus influenzae type b capsular polysaccharide conjugated to tetanus toxoid in preterm infants. Pediatr Infect Dis J 1996;15:525-9.
17. Robinson MJ, Campbell F, Powell P, et al. Antibody response to accelerated Hib immunisation in preterm infants receiving dexamethasone for chronic lung disease. Arch Dis Child Fetal Neonatal Ed 1999;80:F69-71.
18. Khalak R, Pichichero ME, D'Angio CT. Three-year follow-up of vaccine response in extremely preterm infants. Pediatrics 1998;101(4 pt 1):597-603.
19. Kirmani KI, Lofthus G, Pichichero ME, et al. Seven-year follow-up of vaccine response in extremely premature infants. Pediatrics 2002;109:498-504.
20. Booy R, Taylor SA, Dobson SR, et al. Immunogenicity and safety of PRP-T conjugate vaccine given according to the British accelerated immunisation schedule. Arch Dis Child 1992;67:475-8.
21. Heath PT, Booy R, Azzopardi HJ, et al. Antibody concentration and clinical protection after Hib conjugate vaccination in the United Kingdom. JAMA 2000;284:2334-40.
22. British Paediatric Surveillance Unit. 12th Annual Report 1997-8. London: Royal College of Paediatrics and Child Health, September 1998.
23. Falla TJ, Crook DW, Brophy LN, et al. PCR for capsular typing of Haemophilus influenzae. J Clin Microbiol 1994;32:2382-6.
24. Department of Health. NHS Maternity Statistics, England: 1995-96 to 1997-98. Statistical Bulletin 2001/14. London: Department of Health, June 2001.
25. Kayhty H, Peltola H, Karanko V, et al. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J Infect Dis 1983;147:1100.
26. Kayhty H, Eskola J, Peltola H, et al. High antibody responses to booster doses of either Haemophilus influenzae capsular polysaccharide or conjugate vaccine after primary immunization with conjugate vaccines. J Infect Dis 1992;165(suppl 1):S165-6.
27. Eskola J, Kayhty H. Ten years experience with Haemophilus influenzae type b (Hib) conjugate vaccines in Finland. Rev Med Microbiol 1996;7:231-41.
28. Jonsdottir KE, Hansen H, Arnorsson VH, et al. Immunisation against Haemophilus influenzae type b in Iceland Results after 6 years of PRP-D (ProHIBiT). The Icelandic Medical Journal 1996;82:32-8.
29. Heath PT, Bowen-Morris J, Griffiths D, et al. Antibody persistence and Haemophilus influenzae type b carriage after infant immunisation with PRP-T. Arch Dis Child 1997;77:488-92.
30. Booy R, Heath PT, Slack MP, et al. Vaccine failures after primary immunisation with Haemophilus influenzae type-b conjugate vaccine without booster. Lancet 1997;349:1197-202.
31. Shinefield H, Black S, Ray P, et al. Efficacy, immunogenicity and safety of heptavalent pneumococcal conjugate vaccine in low birth weight and preterm infants. Pediatr Infect Dis J 2002;21:182-6.
32. Eskola J, Ward J, Dagan R, et al. Combined vaccination of Haemophilus influenzae type b conjugate and diphtheria-tetanus-pertussis containing acellular pertussis. Lancet 1999;354:2063-8.